Cargando…

Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study

BACKGROUND: Mammography-based breast cancer screening has been widely implemented in many developed countries. Evidence was needed on participation and diagnostic performance of population-based breast cancer screening using ultrasound in China. METHODS: We used data from the Cancer Screening Progra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Yang, Lei, Liu, Shuo, Li, Huichao, Li, Qingyu, Cheng, Yangyang, Wang, Ning, Ji, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600225/
https://www.ncbi.nlm.nih.gov/pubmed/34804981
http://dx.doi.org/10.3389/fonc.2021.776848
_version_ 1784601105711235072
author Zhang, Xi
Yang, Lei
Liu, Shuo
Li, Huichao
Li, Qingyu
Cheng, Yangyang
Wang, Ning
Ji, Jiafu
author_facet Zhang, Xi
Yang, Lei
Liu, Shuo
Li, Huichao
Li, Qingyu
Cheng, Yangyang
Wang, Ning
Ji, Jiafu
author_sort Zhang, Xi
collection PubMed
description BACKGROUND: Mammography-based breast cancer screening has been widely implemented in many developed countries. Evidence was needed on participation and diagnostic performance of population-based breast cancer screening using ultrasound in China. METHODS: We used data from the Cancer Screening Program in Urban China in Beijing from 2014 to 2019 and was followed up until July 2020 by matching with the Beijing Cancer Registry database. Eligible women between the ages of 45 and 69 years were recruited from six districts and assessed their risk of breast cancer through an established risk scoring system. Women evaluated to be at high risk of breast cancer were invited to undergo both ultrasound and mammography. Participation rates were calculated, and their associated factors were explored. In addition, the performance of five different breast cancer screening modalities was evaluated in this study. RESULTS: A total of 49,161 eligible women were recruited in this study. Among them, 15,550 women were assessed as high risk for breast cancer, and 7,500 women underwent ultrasound and/or mammography as recommended, with a participation rate of 48.2%. The sensitivity of mammography alone, ultrasound alone, combined of ultrasound and mammography, ultrasound for primary screening followed by mammography for triage, and mammography for preliminary screening followed by ultrasound for triage were19.2%, 38.5%, 50.0%, 46.2%, and 19.2%, and the specificity were 96.1%, 98.6%, 94.7%, 97.6%, 95.7%, respectively. The sensitivity of combined ultrasound and mammography, ultrasound for primary screening followed by mammography for triage, was significantly higher than mammography alone (p=0.008 and p=0.039). Additionally, ultrasound alone (48,323 RMB ($7,550)) and ultrasound for primary screening followed by mammography for triage (55,927 RMB ($8,739)) were the most cost-effective methods for breast cancer screening than other modalities. CONCLUSIONS: Ultrasound alone and ultrasound for primary screening and mammography are superior to mammography for breast cancer screening in high-risk Chinese women.
format Online
Article
Text
id pubmed-8600225
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86002252021-11-19 Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study Zhang, Xi Yang, Lei Liu, Shuo Li, Huichao Li, Qingyu Cheng, Yangyang Wang, Ning Ji, Jiafu Front Oncol Oncology BACKGROUND: Mammography-based breast cancer screening has been widely implemented in many developed countries. Evidence was needed on participation and diagnostic performance of population-based breast cancer screening using ultrasound in China. METHODS: We used data from the Cancer Screening Program in Urban China in Beijing from 2014 to 2019 and was followed up until July 2020 by matching with the Beijing Cancer Registry database. Eligible women between the ages of 45 and 69 years were recruited from six districts and assessed their risk of breast cancer through an established risk scoring system. Women evaluated to be at high risk of breast cancer were invited to undergo both ultrasound and mammography. Participation rates were calculated, and their associated factors were explored. In addition, the performance of five different breast cancer screening modalities was evaluated in this study. RESULTS: A total of 49,161 eligible women were recruited in this study. Among them, 15,550 women were assessed as high risk for breast cancer, and 7,500 women underwent ultrasound and/or mammography as recommended, with a participation rate of 48.2%. The sensitivity of mammography alone, ultrasound alone, combined of ultrasound and mammography, ultrasound for primary screening followed by mammography for triage, and mammography for preliminary screening followed by ultrasound for triage were19.2%, 38.5%, 50.0%, 46.2%, and 19.2%, and the specificity were 96.1%, 98.6%, 94.7%, 97.6%, 95.7%, respectively. The sensitivity of combined ultrasound and mammography, ultrasound for primary screening followed by mammography for triage, was significantly higher than mammography alone (p=0.008 and p=0.039). Additionally, ultrasound alone (48,323 RMB ($7,550)) and ultrasound for primary screening followed by mammography for triage (55,927 RMB ($8,739)) were the most cost-effective methods for breast cancer screening than other modalities. CONCLUSIONS: Ultrasound alone and ultrasound for primary screening and mammography are superior to mammography for breast cancer screening in high-risk Chinese women. Frontiers Media S.A. 2021-11-04 /pmc/articles/PMC8600225/ /pubmed/34804981 http://dx.doi.org/10.3389/fonc.2021.776848 Text en Copyright © 2021 Zhang, Yang, Liu, Li, Li, Cheng, Wang and Ji https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Xi
Yang, Lei
Liu, Shuo
Li, Huichao
Li, Qingyu
Cheng, Yangyang
Wang, Ning
Ji, Jiafu
Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
title Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
title_full Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
title_fullStr Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
title_full_unstemmed Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
title_short Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
title_sort evaluation of different breast cancer screening strategies for high-risk women in beijing, china: a real-world population-based study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600225/
https://www.ncbi.nlm.nih.gov/pubmed/34804981
http://dx.doi.org/10.3389/fonc.2021.776848
work_keys_str_mv AT zhangxi evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT yanglei evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT liushuo evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT lihuichao evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT liqingyu evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT chengyangyang evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT wangning evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy
AT jijiafu evaluationofdifferentbreastcancerscreeningstrategiesforhighriskwomeninbeijingchinaarealworldpopulationbasedstudy